ARMANDO ACOSTA RUIZ: Open Payments
NPI 1013334333 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,728 in 94 payments from 16 companies in 2025. Trend: 2023 $2,589 · 2024 $1,753 · 2025 $1,728
Food & beverage: $1,728
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $344 |
| ABBVIE INC. | 14 | $247 |
| Lilly USA, LLC | 13 | $239 |
| PFIZER INC. | 12 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| Novartis Pharmaceuticals Corporation | 6 | $108 |
| Astellas Pharma US Inc | 5 | $95 |
| Abbott Laboratories | 5 | $94 |
| Paratek Pharmaceuticals, Inc. | 4 | $72 |
| Novo Nordisk Inc | 3 | $63 |
Products named: MOUNJARO, UBRELVY, Kerendia, LEQVIO, Veozah, FARXIGA, FREESTYLE LIBRE 3, JARDIANCE.
Industry payments across FL — which companies pay providers there.
